Divas Pharma Ltd
09488738
Some Concerns
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 13/03/2015
VALIDATION CONSULTANT
BRITISH · ENGLAND · Age 46
Also on 1 other board
director · Since 01/07/2018
DIRECTOR
BRITISH · ENGLAND · Age 45
Also on 2 other boards
Persons with Significant Control
Mr Pradeep Kumar Adapala
British · England · Age 46
52, George Wicks Way, Chelmsford, CM1 6FU
Notified 09/09/2016
Mrs Divya Adapala
British · England · Age 45
167-169, Great Portland Street, London, W1W 5PF
Notified 21/01/2026
Charges1 outstanding
HSBC UK BANK PLC
CompanyRankvs 49+ SIC 21200 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£186k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£194k
Working capital
Current Assets
£259k
Current Liabilities
£65k
Fixed Assets
£17k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.98 | +£11k |
| 2024 | 3.83 | -£4k |
| 2023 | 6.24 | +£46k |
| 2022 | 5.11 | +£35k |
| 2021 | 6.43 | +£9k |
| 2020 | 3.45 | +£29k |
| 2019 | 2.46 | — |
Derived from filed accounts. Not audited figures.